Catalyst Wire Dossier Catalyst Wire Dossier

bilastine ophthalmic solution

bilastine · Faes Farma, S.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for bilastine ophthalmic solution, covering 2021-11-24 to 2021-11-24. Get the full timeline:

Most recent: Clinical Trial Update: A Single-Center, Phase 2 Study Evaluating Bilastine Ophthalmic Solution in the CAC® Model [Phase 2]

See pricing